The company have significantly improved the progress of the innovative solution for ATTR-CM, leveraging Attruby. Early clinical information reveals promising benefits for individuals suffering from the debilitating disease. The focus highlights BridgeBio's dedication to treating significant patient requirements in the cardiology field. … Read More